XETRA - Delayed Quote EUR

aap Implantate AG (AAQ1.DE)

Compare
1.8900
+0.1500
+(8.62%)
At close: January 17 at 5:38:27 PM GMT+1

Key Executives

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Rubino Di Girolamo Chairman of the Management Board & CEO 205k -- 1962
Ms. Agnieszka Mierzejewska Member of Management Board & COO -- -- 1983
Fabian Franke Head of Investor Relations -- -- --

aap Implantate AG

Lorenzweg 5
Berlin, 12099
Germany
49 30 75019 0 https://www.aap.de
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
87

Description

aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. It offers LOQTEQ, an anatomical plating system for fracture treatment of ankle joint, knee, elbow, wrist, and shoulder; and straight plates and cannulated screws. The company sells its products directly to hospitals, purchasing groups, and hospital groups in Germany through a network of distributors. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Corporate Governance

aap Implantate AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 15, 2024 at 10:59 AM UTC - November 18, 2024 at 12:00 PM UTC

aap Implantate AG Earnings Date

Recent Events

Related Tickers